BridgeMD
New treatment option for Scoliosis Neuromuscular
Official title Post-market Clinical Follow-up Study of NEMOST V2
ClinicalTrials.gov ID: NCT07403084
What this study is testing
- What it's testing
- The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children. As part of post-market surveillance, EUROS is conducting a retrospective and prospective study to collect clinical and radiological data on the NEMOST growth domino.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 to 17
You may be able to join if
- Idiopathic, congenital, neuromuscular, or syndromic scoliosis : Progressive spinal deformity not managed by orthopedic treatment, and requiring...
- The patient, as well as their parents or legal guardians, are informed of the participation in the study.
- Patients aged from 5 to 17 yeas old, excepted the one who still have a potential for growth
You likely can't join if
- signs of local inflammation;
- acute or chronic, local or systemic infections ;
- non-reducible scoliosis ;
- pathological obesity ;
- allergy or intolerance to implanted materials;
- insufficiency or absence of tissue coverage. The NEMOST implant should not be used in a spine that has already been instrumented or fused.
The study team makes the final eligibility decision.
Where it's taking place
- Nice, Provence-Alpes-Côte d'Azur Region, France
- Bordeaux, France
- Lyon, France
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nice, Provence-Alpes-Côte d'Azur Region, France; Bordeaux, France; Lyon, France; Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.